Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obervation Letter
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
Letters to the Editor - Letter in Response to Previously Published Articles
2019:85:1;87-88
doi: 10.4103/ijdvl.IJDVL_843_18
PMID: 30516169

Authors' reply

Vishal Gupta, Vinod K Sharma
 Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Vinod K Sharma
Department of Dermatology and Venereology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029
India
Published: 05-Dec-2018
How to cite this article:
Gupta V, Sharma VK. Authors' reply. Indian J Dermatol Venereol Leprol 2019;85:87-88
Copyright: (C)2019 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

We thank the authors for their interest in our article on the controversies surrounding the nosology of ashy dermatosis, lichen planus pigmentosus and pigmented cosmetic dermatitis.[1] These entities share several clinical and histopathological features, and their nomenclature has been debated endlessly.[2],[3],[4],[5],[6],[7] The focus, so far, has been more on highlighting the subtle differences between them, instead of finding answers to the more meaningful questions such as their etiopathogenesis, natural course and effective treatment options. Lack of consensus on the nomenclature of these poorly understood disorders has only hindered research in this field. We prefer “lumping” to “splitting” these remarkably similar entities to facilitate communication among dermatologists and researchers, and think of them as a clinical reaction pattern with several poorly understood triggers. Although the authors largely concur with our unifying idea, they differ on the choice of the umbrella term and favor “acquired dermal macular hyperpigmentation of varied etiology.” We would like to point out that our objective was not to propose another term, but rather to question the need for different terms for what appears to be spectral manifestations of a single disease process. We simply reiterated the term (“macular pigmentation of uncertain etiology”) which was already in existence to avoid further confusion.[4] Recently, a global consensus statement on the terminology of these conditions has been released which states that lichen planus pigmentosus, ashy dermatosis and erythema dyschromicum perstans are in the spectrum of acquired macular pigmentation of uncertain etiology.[8]

The proposed name “acquired dermal macular hyperpigmentation of varied etiology” by the authors is a good descriptive term, especially as it emphasizes the dermal location of the pigment. However, we feel that the current knowledge regarding the etio-pathogenesis of these conditions is not sufficient to justify the phrase 'of varied etiology' in the name. Some of the ‘etiologies’ such as hepatitis C infection are probably just an association,[9] while the role of hormonal factors has been speculated owing to the frequent occurrence of lichen planus pigmentosus in perimenopausal women.[10] Although photosensitizers such as amla oil and mustard oil have often been implicated as causative factors, there is no conclusive evidence to support this hypothesis.[11] In fact, the global consensus forum concluded “these conditions are unlikely to be due to a particular oil applied on the skin or a particular dietary ingredient” because of the diverse cultural practices in different regions where these diseases occur.[8] We have previously reported patch test positivity in about one-third of our patients with lichen planus pigmentosus on face.[12] Similar results have been reported by others as well, raising the possibility of certain contact allergens triggering the disease in a subset of patients.[5],[13] However, the etiology remains largely unknown in the vast majority of patients and mandates further research. Indeed, the phrase “of uncertain etiology” may serve as a reminder of the uncertain aspects of this enigmatic group of pigmentary dermatoses and give a fresh impetus to our efforts in identifying their cause.

The authors further contend that entities such as fixed drug eruptions, melasma, ochronosis, macular amyloidosis, drug-induced and post inflammatory hyperpigmentation, nevus of Ota and other dermal melanocytoses could also be encompassed in the term acquired macular pigmentation of uncertain etiology. However, etiology, and even pathogenesis, of several of these conditions is no longer uncertain; for example, drug eruptions (T-cell-mediated delayed hypersensitivity to drug hapten),[14] exogenous ochronosis (long-term hydroquinone use or related products),[15] macular amyloidosis (constant friction)[16] and postinflammatory hyperpigmentation (sequelae of an inflammatory dermatosis). In fact, it is suggested to exclude hyperpigmented macules with a definite etiology (such as drug eruption, postinflammatory) from this rubric.[8]

Lastly, we feel that the “name” itself may not be so relevant as long as a consensus is reached, and its connotations are understood clearly by the researchers worldwide. We hope that this debate on the nomenclature ends soon, and the focus is shifted to furthering meaningful research that can translate into results for our patients suffering from this distressing condition. The nomenclature can be changed as new information comes to light.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References
1.
Gupta V, Sharma VK. Ashy dermatosis, lichen planus pigmentosus and pigmented cosmetic dermatitis: Are we splitting the hair? Indian J Dermatol Venereol Leprol 2018;84:470-4.
[Google Scholar]
2.
Ghosh A, Coondoo A. Lichen planus pigmentosus: The controversial consensus. Indian J Dermatol 2016;61:482-6.
[Google Scholar]
3.
Zaynoun S, Rubeiz N, Kibbi AG. Ashy dermatoses – A critical review of the literature and a proposed simplified clinical classification. Int J Dermatol 2008;47:542-4.
[Google Scholar]
4.
Chandran V, Kumarasinghe SP. Macular pigmentation of uncertain aetiology revisited: Two case reports and a proposed algorithm for clinical classification. Australas J Dermatol 2017;58:45-9.
[Google Scholar]
5.
Bhutani LK. Pigmented contact dermatitis vs. lichen planus pigmentosus. Int J Dermatol 1977;16:860-2.
[Google Scholar]
6.
Bhutani LK. Ashy dermatosis or lichen planus pigmentosus: What is in a name? Arch Dermatol 1986;122:133.
[Google Scholar]
7.
Nakayama H. Authors' reply: Pigmented contact dermatitis vs. lichen planus pigmentosus. Int J Dermatol 1977;16:861-2.
[Google Scholar]
8.
Kumarasinghe SP, Pandya A, Chandran V, Rodrigues M, Dlova NC, Kang HY, et al. Aglobal consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentationand Riehl's melanosis. Int J Dermatol 2018; doi: 10.1111/ijd.14189. [Epub ahead of print].
[Google Scholar]
9.
Al-Mutairi N, El-Khalawany M. Clinicopathological characteristics of lichen planus pigmentosus and its response to tacrolimus ointment: An open label, non-randomized, prospective study. J Eur Acad Dermatol Venereol 2010;24:535-40.
[Google Scholar]
10.
Robles-Méndez JC, Rizo-Frías P, Herz-Ruelas ME, Pandya AG, Ocampo Candiani J. Lichen planus pigmentosus and its variants: Review and update. Int J Dermatol 2018;57:505-14.
[Google Scholar]
11.
Kanwar AJ, Dogra S, Handa S, Parsad D, Radotra BD. A study of 124 Indian patients with lichen planus pigmentosus. Clin Exp Dermatol 2003;28:481-5.
[Google Scholar]
12.
Sharma VK, Gupta V, Pahadiya P, Vedi KK, Arava S, Ramam M, et al. Dermoscopy and patch testing in patients with lichen planus pigmentosus on face: A cross-sectional observational study in fifty Indian patients. Indian J Dermatol Venereol Leprol 2017;83:656-62.
[Google Scholar]
13.
Tienthavorn T, Tresukosol P, Sudtikoonaseth P. Patch testing and histopathology in Thai patients with hyperpigmentation due to erythema dyschromicum perstans, lichen planus pigmentosus, and pigmented contact dermatitis. Asian Pac J Allergy Immunol 2014;32:185-92.
[Google Scholar]
14.
Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions-new concepts. Clin Exp Allergy 2007;37:989-99.
[Google Scholar]
15.
Levin CY, Maibach H. Exogenous ochronosis. An update on clinical features, causative agents and treatment options. Am J Clin Dermatol 2001;2:213-7.
[Google Scholar]
16.
Siragusa M, Ferri R, Cavallari V, Schepis C. Friction melanosis, friction amyloidosis, macular amyloidosis, towel melanosis: Many names for the same clinical entity. Eur J Dermatol 2001;11:545-8.
[Google Scholar]

Fulltext Views
233

PDF downloads
109
Show Sections